Sandoz Group Ltd
SDZ
ISIN CH1243598427 / Valor 124359842
Sandoz Group Ltd
UMushroom community rating:
About company
Sandoz Group Ltd is a global pharmaceutical company focused on the development, manufacture and commercialization of off‑patent medicines, including generic small‑molecule drugs, complex sterile injectables and biosimilars; it supplies finished dosage forms and active pharmaceutical ingredients to hospitals, pharmacies and wholesalers across major markets. Historically the generics division of Novartis, Sandoz was separated and listed as an independent company in 2023 and operates a network of manufacturing and R&D sites to support regulatory submissions, lifecycle management and licensing partnerships for cost‑effective alternatives to originator therapies. Its portfolio spans multiple therapeutic areas and its commercial model emphasizes scale in production and regulatory expertise to compete in established and emerging markets.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
34906 M
Market cap (USD)
449,845
Daily traded volume (Shares)
37.28 / 36.88
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Robin Saint-Ghislain
Edoardo Pistolese
Adrian Estermann
EQUITIES OF THE SAME SECTOR
